ArticleClinical immunology (Orlando, Fla.)2020
The first case of COVID-19 treated with the complement C3 inhibitor AMY-101.
Sara Mastaglio et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
207 papers cite itlatest 60 shown
this paperpooled ittrialcites it